Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)
Condition: ADHD Intervention: Drug: Amphetamine Extended Release (ER) Tablet 20 mg Sponsors: Tris Pharma, Inc.; Massachusetts General Hospital; Massachusetts Institute of Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials